By: Fitzsimons Innovation Community
When Israel Villaseñor, Chief Strategy Officer of IMD Path, talks about his company’s journey to Colorado, he uses a word that perfectly captures how it all happened: serendipitous. What started as a California-focused molecular diagnostics company has found a true home right here at Fitzsimons Innovation Community.
“If it wasn’t for networking and having connections, we would have never known about Fitzsimons,” Villaseñor reflects. “We would have probably ended up just locking ourselves into California and not thinking about Colorado.”
From Stanford Knowledge to Colorado Innovation
IMD, short for Integrated Molecular DiagnosticsTM, specializes in oncology molecular diagnostics, focusing on personalized cancer treatment. The company’s founding team developed their expertise at Stanford University, where they learned firsthand how teaming with academic institutions creates success in oncology care by integrating oncologists, pathologists, and laboratories to bridge information quickly.
The knowledge…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
